Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
企業コードAORT
会社名Artivion Inc
上場日Feb 12, 1993
最高経営責任者「CEO」Mackin (James Patrick)
従業員数1600
証券種類Ordinary Share
決算期末Feb 12
本社所在地1655 Roberts Boulevard N W
都市KENNESAW
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号30144
電話番号17704193355
ウェブサイトhttps://artivion.com/
企業コードAORT
上場日Feb 12, 1993
最高経営責任者「CEO」Mackin (James Patrick)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし